{"id":333396,"date":"2026-10-30T13:20:35","date_gmt":"2026-10-30T07:50:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/ajanta-pharma-q2-results-fy27-pat-388-crore\/"},"modified":"2026-10-30T13:20:35","modified_gmt":"2026-10-30T07:50:35","slug":"ajanta-pharma-q2-results-fy27-pat-388-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ajanta-pharma-q2-results-fy27-pat-388-crore\/","title":{"rendered":"Ajanta Pharma Q2 Results FY27: PAT Jumps 49.18% as Revenue Rises 32.53%, Revenue Rs 1,794.16 Cr, PAT Rs 388.14 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Ajanta Pharma Q2 Results FY27 were declared on 30 October 2026 on a consolidated basis, covering the July to September 2026 quarter. Ajanta Pharma reported revenue of Rs 1,794.16 Cr, up 32.53% YoY, and net profit of Rs 388.14 Cr, up 49.18% YoY. These quarterly results compare the latest quarter with the same quarter last year. The YoY growth figures for revenue and net profit are broken down in the sections below.<\/p>\n<\/div>\n

Ajanta Pharma Ltd<\/a> (AJANTPHARM) Q2 Results FY27 announced on 30 October 2026, covering the company’s financial performance for the July to September quarter. The Ajanta Pharma Q2 Results FY27 show revenue of Rs 1,794.16 Cr and net profit of Rs 388.14 Cr, reported on a Consolidated basis. The results date of 30 October 2026 follows the board meeting and the exchange filing, and the consolidated results are the basis for every figure here.<\/p>\n

This Ajanta Pharma Q2 Results article is a results analysis built on the filing, covering financial highlights, business drivers, outlook and risks. Univest readers can use it alongside the NSE and BSE listings for AJANTPHARM, and the Financial Highlights table follows next.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n